HELE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Helen of Troy Ltd (HELE) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is deteriorating, analysts have lowered price targets, and there are no strong positive catalysts or trading signals to support a buy decision. Additionally, technical indicators suggest the stock is overbought, and trading sentiment is neutral.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 82.617, signaling the stock is overbought. The stock is trading near its resistance level (R1: 16.654), suggesting limited upside potential in the short term. Moving averages are converging, indicating a lack of clear directional trend.
NULL identified. The MACD indicates bullish momentum, but this is countered by overbought conditions and lack of significant positive news.
Analysts have significantly lowered price targets (UBS to $16, Canaccord to $18).
Financial underperformance with declining revenue, net income, and EPS.
Legal investigation by Faruq & Faruqi, LLP.
Overbought technical conditions (RSI at 82.617).
In Q3 2026, revenue dropped by -3.37% YoY to $512.83M. Net income plummeted by -269.41% YoY to -$84.06M. EPS fell by -268.20% YoY to -3.65. Gross margin declined by -4.07% YoY to 46.87%. These metrics indicate significant financial deterioration.
Analysts have a neutral to bearish outlook. UBS lowered the price target to $16 and maintained a Neutral rating, citing risks from inflation. Canaccord lowered the price target to $18, maintaining a Hold rating, citing sector underperformance. Goldman Sachs downgraded the stock to Sell earlier in the year, reflecting weak fundamentals.
